Tokyo, Japan

Naoto Katoh



 

Average Co-Inventor Count = 10.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Naoto Katoh: Innovator in Therapeutic Compounds

Introduction

Naoto Katoh is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. With a total of 3 patents to his name, Katoh's work focuses on innovative solutions for various medical conditions.

Latest Patents

Among his latest patents is the invention of Bicyclic 1,4-diazepanones and their therapeutic uses. This patent provides compounds of a specific formula, including stereoisomers and pharmaceutically acceptable salts. The invention also details a composition that includes these compounds, along with methods for treating diseases and disorders that respond to the modulation of skeletal sarcomere contractility. This innovative approach has the potential to address various health issues effectively.

Career Highlights

Throughout his career, Naoto Katoh has worked with notable companies in the pharmaceutical industry, including Cytokinetics, Inc. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in therapeutic applications.

Collaborations

Naoto has collaborated with several professionals in his field, including Bradley Paul Morgan and Chris Evans. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in therapeutic research.

Conclusion

Naoto Katoh's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…